Abstract
Results
To uncover sequence elements that drive the use of poly(A) sites in specific conditions, we have developed PAQR, a method for quantifying poly(A) site use from RNA sequencing (RNA-seq) data and KAPAC, an approach that infers activities of oligomeric sequence motifs on poly(A) site choice. We demonstrate that these tools enable the discovery of sequence specificity and the binding site position-dependent activity of RNA-binding proteins (RBPs) on pre-mRNA cleavage and polyadenylation (CPA), from RNA-seq data obtained upon perturbing RBP expression. Furthermore, application of PAQR and KAPAC to RNA sequencing data from normal and tumor tissue samples uncovered sequence motifs that can explain changes in CPA within specific cancer types. In particular, our analysis points to the polypyrimidine tract binding protein 1 as key regulator of poly(A) site choice in glioblastoma.
Conclusions
The PAQR and KAPAC methods that we introduced here enable the identification of regulatory factors that shape 3' UTR processing and the characterization of their binding
Background
The 3' ends of most eukaryotic mRNAs are generated through endonucleolytic cleavage and polyadenylation (CPA) [1] [2] [3] . These steps are carried out in mammalian cells by a 3' end processing complex composed of the cleavage and polyadenylation specificity factor (which includes the proteins CPSF1 (also known as CPSF160), CPSF2 (CPSF100), CPSF3 (CPSF73), CPSF4 (CPSF30), FIP1L1 and WDR33), the mammalian cleavage factor I (CFIm, a tetramer of two small, NUDT21 (CFIm 25) subunits, and two large subunits, of CPSF7 (CFIm 59) and/or CPSF6 (CFIm 68)), the cleavage factor II (composed of CLP1 and PCF11), the cleavage stimulation factor (CstF, a trimer of CSTF1 (CstF50), CSTF2 (Cstf64) and CSTF3 (CstF77)), symplekin (SYMPK), the poly(A) polymerase (PAPOLA, PAPOLB, PAPOLG) and the nuclear poly(A) binding protein (PABPN1) [3, 4] . Crosslinking and immunoprecipitation (CLIP) revealed the distribution of core 3' end processing factor binding sites in pre-mRNAs [5] and the minimal polyadenylation specificity factor that recognizes the polyadenylation signal, consisting of the CPSF1, CPSF4, FIP1L1, and WDR33 proteins, has been identified [6, 7] .
Most genes have multiple poly(A) sites (PAS), which are differentially processed across cell types [8] , likely due to cell type-specific interactions with RBPs. The length of 3' UTRs is most strongly dependent on the mammalian cleavage factor I (CFIm), which promotes the use of distal poly(A) sites [5, [9] [10] [11] [12] . Reduced expression of CFIm 25 has been linked to 3' UTR shortening, cell proliferation and oncogene expression in glioblastoma cell lines [11] , while increased levels of CFIm 25 due to gene duplication has been linked to intellectual disability [13] . The CSTF2 component of the CstF subcomplex also contributes to the selection of poly(A) sites [5, 14] , but in contrast to CFIm, depletion of CSTF2 leads to increased use of distal poly(A) sites, especially when the paralogous CSTF2T is also depleted [14] . PCF11 and FIP1L1 proteins similarly promote the use of proximal poly(A) sites [12] .
Many splicing factors modulate 3' end processing. Most strikingly, the U1 small nuclear ribonucleoprotein (snRNP) promotes transcription, masking poly(A) sites whose processing would lead to premature CPA, through a 'telescripting' mechanism [15, 16] . The U2AF65 spliceosomal protein interacts with CFIm [17] and competes directly with the heterogeneous nucleoprotein C (HNRNPC) for binding to uridine(U)-rich elements, regulating the splicing and thereby exonization of Alu elements [18] . HNRNPC represses CPA at poly(A) sites where U-rich sequence motifs occur [19] . Other splicing factors that have been linked to poly(A) site selection are the neuron-specific NOVA1 protein [20] , the nuclear and cytoplasmic poly(A) binding proteins [12, 21] , the heterogeneous ribonucleoprotein K (HNRNPK) [22] , and the poly(C) binding protein (PCBP1) [23] . However, the mechanisms remain poorly understood. An emerging paradigm is that position-dependent interactions of pre-mRNAs with RBPs influence poly(A) site selection, as well as splicing [24] . 'Impact maps' are used to visualize the relationship between the location of RBP binding sites and the response of exons to perturbations in RBP expression processing of exons. However, whether 'impact maps' can be inferred directly from genome-wide RNA sequencing data obtained upon perturbing RBP expression is not known.
To address this problem, we have developed KAPAC (for k -mer a ctivity on p oly a denylation site c hoice), a method that infers position-dependent activities of sequence motifs on 3' end processing from changes in poly(A) site usage between conditions. As 3' end sequencing remains relatively uncommon, we have also developed PAQR, a method for p oly a denylation site usage q uantification from R NA sequencing data, that allows us to evaluate 3' end processing in data sets such as those from The Cancer Genome Atlas (TCGA) Research Network [25] . We demonstrate that KAPAC identifies binding motifs and position-dependent activities of regulators of CPA from RNA-seq data obtained upon the knock-down of these RBPs, and in particular, that CFIm promotes CPA at poly(A) sites located~50 to 100 nucleotides (nt) downstream of the CFIm binding motifs. KAPAC analysis of TCGA data reveals pyrimidine-rich elements associated with the use of poly(A) sites in cancer and implicates the polypyrimidine tract-binding protein 1 (PTBP1) in the regulation of 3' end processing in glioblastoma.
Results

Inferring sequence motifs active on PAS selection with KAPAC
As binding specificities of RBPs have only recently been started to be determined in vivo in high-throughput [26] , we developed an unbiased approach, evaluating the activity of all possible sequences of length k ( k -mers, with k in the range of RBP-binding site length, [3] [4] [5] [6] nucleotides [27] ) on PAS usage. Briefly, we first compute the relative use of each PAS p among the P poly(A) sites ( P > 1) in a given terminal exon across all samples s, as , where is the number of reads observed for poly(A) site p in sample s
( Figure 1A ). KAPAC aims to explain the observed changes in relative poly(A) site usage in terms of the number of counts of a k -mer k located at a specific distance relative U p,s N p,k to the poly(A) site p ( Figure 1B-C) . Running KAPAC for various relative distances ( Figure   1D ) allows the identification of the most significantly active k -mers as well as the distance from the PAS where individual k-mers have the highest activity. Tabulation of k -mer counts for windows located at defined distances relative to poly(A) sites.
(C) Based on the observed changes in poly(A) site usage across conditions and the counts of k -mers in windows located at specific distances from the poly(A) sites, KAPAC infers k -mer activities in each condition and ranks k -mers based on the absolute z-score of the mean activity difference in the two conditions. (D) Fitting the KAPAC model for windows located at specific distances relative to poly(A) sites, position-dependent activities of sequence motifs on poly(A) site use are inferred.
KAPAC uncovers expected position-specific activities of RBPs on pre-mRNA 3' end processing
To evaluate KAPAC we analyzed RNA 3' end sequencing data that were obtained after perturbation of known RBP regulators of cleavage and polyadenylation. Consistent with the initial study of poly(C) binding protein 1 (PCBP1) role in cleavage and polyadenylation [23] , as well as with the density of its CCC -(C) 3 -binding element around PAS that do and PAS that do not respond to PCBP1 knock-down (Figure 2A ), KAPAC revealed that (C) 3 motifs strongly activate the processing of poly(A) sites located 25-100 nucleotides downstream
As in a previous study we found that the multi-functional heterogeneous ribonucleoprotein C (HNRNPC) modulates 3' end processing (see also Figure 2D ), we also applied KAPAC to 3' end sequencing data obtained upon the knock-down of this protein. Indeed, we found that (U) n sequences ( nucleotides) have a strongly repressive activity on poly(A) site n = 3 − 5 choice, which, reminiscent of HNRNPC's effect on exon inclusion [18] , extends to a broad window, from approximately -200 nucleotides upstream to about 50 nucleotides downstream of poly(A) sites ( Figure 2E-F) . In contrast to the density of (U) 5 motifs, which peaks immediately downstream of poly(A) sites, KAPAC inferred an equally high repressive activity of (U) 5 motifs located upstream of the poly(A) site.
These results demonstrate that being provided only with estimates of poly(A) site expression in different conditions, KAPAC uncovers both the sequence specificity of the RBP whose expression was perturbed in the experiment, and the position-dependent, activating or repressing activity of the RBP on poly(A) site choice. The PAQR method to estimate relative PAS use from RNA-seq data As 3' end sequencing data remain relatively uncommon, we sought to quantify poly(A) site use from RNA sequencing data. The drop in coverage downstream of proximal PAS has been interpreted as evidence of PAS processing, generalized by the DaPars method to identify changes in 3' end processing genome-wide [11] . However, DaPars (with default settings) reported only 5 targets from the RNA-seq data obtained upon the knockdown of HNRNPC [28] , and they did not include the previously validated HNRNPC target CD47 [19] , whose distal PAS is preferentially used upon HNRNPC knockdown ( Figure 3A) . Figure 1) , so did the motif activities inferred by KAPAC based on these estimates ( Figure 3B ). These results prompted us to develop PAQR, a method to quantify PAS use from RNA-seq data ( Figure 3C ). PAQR uses read coverage profiles to progressively segment 3' UTRs at annotated poly(A) sites. At each step, it infers the breakpoint that maximizes the ratio of the squared deviation from the mean coverage of a 3' UTR segment when dividing the segment in two regions with distinct mean coverage ( Figure   3C and Methods) as opposed to considering as a single segment with one mean coverage.
A key aspect of PAQR is that it only attempts to segment the 3' UTRs at experimentally identified poly(A) sites, from an extensive catalog that was recently constructed [19] . Using the HNRNPC knock-down data set that was obtained independently [28] for benchmarking, we found that the PAQR-based quantification of PAS use led to much more reproducible HNRNPC binding motif activity and more significant difference of mean z-scores between Similar HNRNPC activity on PAS use is inferred by KAPAC from both PAS use estimates generated by PAQR from RNA sequencing data, and from PAS use measured directly by 3' end sequencing ( Figure 2E ).
KAPAC reveals a position-dependent activity of CFIm binding on cleavage and polyadenylation
As KAPAC allows us to infer position-dependent effects of RBP binding on 3' end processing, we next sought to unravel the mechanism of CFIm, the 3' end processing factor with a relatively large impact on 3' UTR length [5, 9, 10, 12] . We thus depleted either the Figure 4C ), which is also enriched at distal PAS [5] . Interestingly, the activity profile further suggests that UGUA motifs located downstream of PAS may repress processing of these sites, leading to an apparent decreased motif activity when CFIm expression is high.
We repeated these analyses on RNA-seq data obtained independently from HeLa cells depleted of CFIm 25 [11] , obtaining similar activity profile ( Figure 4D 
KAPAC implicates the pyrimidine tract binding proteins in 3' end processing in glioblastoma
We then asked whether KAPAC can uncover a role of CFIm 25 in 3' UTR shortening in glioblastoma (GBM), as has been previously suggested [11] . 3' UTRs are indeed markedly shortened in these tumors ( Figure 5A ) and the activity profile of the UGUA motif ( Figure 5B) was similar to that inferred from the CFIm 25/68 knock-down data ( Figure 4D ). However, UGUA was not among the 20 motifs that most significantly explained the change in PAS usage in these samples. Rather, KAPAC revealed that variants of the CU dinucleotide repeat, located from~25 nt upstream to~75 nt downstream of PAS, are most significantly associated with the change in PAS usage in tumors compared to normal samples ( Figure   5B , C). Among the many proteins that can bind polypyrimidine motifs, the mRNA level of the pyrimidine tract binding protein 1 (PTBP1) was strongly anti-correlated with the median average length of terminal exons in this set of samples ( Figure 5D ). This suggested that PTBP1 masks the distally-located, CU repeat-containing PAS, which are processed only when PTBP1 expression is low, as it is in normal cells. Indeed, 180 of the 202 sites where the CU repeat motif was predicted to be active, were located most distally in the corresponding terminal exons. As with HNRNPC, a seemingly parallel repressive activity of PTBP1 on exon inclusion was reported before [29] . The PTBP1 crosslinking and immunoprecipitation data recently generated by the ENCODE consortium [30] confirmed the enriched binding of the protein downstream of the PAS of CU-containing, KAPAC-predicted targets ( Figure 5E ). Furthermore, the enrichment of PTBP1-eCLIP reads is highest for the highest scoring PTBP1 targets ( Figure 5F ), a result which is not explained by the expression level of these categories of genes. These results indicate that PTBP1 is a more likely regulator of PAS use in glioblastoma than CFIm 25. Although the UGUA motif has the expected KAPAC-inferred activity profile in this data set, the changes in PAS use are best explained by CU dinucleotide-containing repeats (inset). led to the suggestion that overexpression of this 3' end processing factor plays a role in lung cancer [31] . Applying KAPAC to 56 matching normal -tumor paired, lung adenocarcinoma samples, we did not find any motifs strongly associated with PAS use changes in this cancer. In particular, we did not recover G/U-rich motifs, as would be expected if CSTF2
were responsible for these changes [31] . This was not due to functional compensation by the paralogous CSTF2T, as the expression of CSTF2T was uncorrelated with the 3' UTR length ( Figure 6C) . Rather, the CSTF2-specific GU repeat motif had variable activity between patients, and did not exhibit a peak immediately downstream of the PAS (Figure 6D ), where CSTF2 is known to bind [5] . Thus, as in glioblastoma, PAS selection in lung adenocarcinoma likely involves factors other than core 3' end processing components.
Exploration of other cancer types for which many paired tumor -normal tissue samples were available revealed that U-rich motifs are more generally significantly associated with changes in PAS use in these conditions (Supplementary Table 2 
Discussion
Sequencing of RNA 3' ends has uncovered a complex pattern of PAS and 3' UTR usage across cell types and conditions, and particularly that the length of 3' UTRs increases upon cell differentiation and decreases upon proliferation [32, 33] . However, the responsible regulators remain to be identified.
The knock-down of most 3' end processing factors leads to short 3' UTRs [12] .
Paradoxically, similar 3' UTR shortening is also observed in cancers, in spite of a positive correlation between expression of 3' end processing factors and the proliferative index of cells [3] . This may suggest that 3' end processing factors are not responsible for 3' UTR processing in cancers, and that other regulators remain to be discovered. However, the possibility remains that 3' end processing factors, although highly expressed, do not match the increased demand for processing in proliferating cells. Although reduced levels of CFIm observations that PTBP1 acts antagonistically to CSTF2, repressing PAS usage [34] , and that increased PTBP1 expression, as we observed in glioblastoma tumors, promotes proliferation and migration in glioblastoma cell lines [35] . Our analysis demonstrates that de novo , unbiased, motif analysis of tumor data sets can reveal specific regulators of PAS usage. At the same time, it underscores the importance of assessing the RNA integrity of the analyzed samples, as variations in the degree of RNA degradation between samples can lead to inaccurate estimates of gene expression levels.
In spite of mounting evidence for the role of CFIm in the regulation of polyadenylation at alternative PAS in terminal exons, its mechanism has remained somewhat unclear.
'Canonical' PAS, containing consensus signals for many of the 3' end processing factors including CFIm, tend to be located distally in 3' UTRs [5] . If core 3' end processing factors bind to specific PAS and select them for processing, reducing the concentration of 3' end processing factors should increase the stringency of PAS selection. Yet the siRNA-mediated knockdown of CFIm leads to increased processing at proximal sites, and not to preferential processing of the 'high-affinity', distal PAS. Here we have found that CFIm indeed promotes the usage of distal PAS to which it binds, while CFIm binding motifs are depleted at both the proximal and the distal PAS of terminal exons whose processing is insensitive to CFIm level.
Therefore, the decreased processing of distal PAS upon CFIm knock-down is not explained by a decreased 'affinity' of these sites. A model that remains compatible with the observed pattern of 3' end processing is the so-called 'kinetic' model, whereby reducing the rate of processing at a distal, canonical site when the regulator is limiting, leaves sufficient time for the processing of a suboptimal proximal site. Kinetic aspects of pre-mRNA processing have started to be investigated in cell lines that express slow and fast-transcribing RNA polymerase II (RNAPII) [36] . Analyzing RNA-seq data from these cells, we found that terminal exons that respond to CFIm knock-down in our data, underwent more pronounced shortening in cells expressing the slow polymerase (Supplementary Figure 3) , in agreement with the kinetic model. Nevertheless, this effect was also apparent for exons in which proximal and distal poly(A) sites were located far apart, it was not limited to CFIm targets.
Furthermore, the changes in 3' UTR length in a sample from the fast RNAPII-expressing cell line were surprisingly similar to the changes we observed for the slow polymerase. Thus, current data do not provide unequivocal support to the kinetic model underlying the relative increase in processing of proximal PAS upon CFIm knock-down.
Generalized linear models have been widely used to uncover transcriptional regulators that implement gene expression programs in specific cell types [37, 38] . Similar approaches have not been applied to 3' end processing, possibly because the genome-wide mapping of 3' end processing sites has been lagging behind the mapping of transcription start sites. Here we demonstrate that the modeling of PAS usage in terms of motifs in the vicinity of PAS can reveal global regulators, while the reconstructed position-dependent activity of their corresponding motifs provides insights into their mechanisms. Interestingly, some of the proteins that we touched upon in our study are splicing factors. This underscores a general coupling between splicing and polyadenylation that has been long surmised (e.g. [17] ), and for which evidence has started to emerge [39] . Interestingly, the activities of splicing factors on poly(A) site choice paralleled the activities of these factors on splice site selection.
Specifically, we found that both HNRNPC, which functions as an 'RNA nucleosome' in packing RNA and masking decoy splice sites [24] , and PTBP1 repress the processing of the PAS to which they bind. This unexpected concordance in activities suggests that other splicing factors simultaneously modulating 3' end processing are to be uncovered. Splicing is strongly perturbed in cancers [40] , and the role of splicing factors in the extensive change of the polyadenylation landscape remains to be defined.
Sequencing of RNA 3' ends has greatly facilitated the study of 3' end processing dynamics.
However, such data remain relatively uncommon, and many large-scale projects have already generated a wealth of RNA sequencing data that could, in principle, be mined to uncover regulators of cleavage and polyadenylation. We found a previously proposed method for inferring the relative use of alternative PAS from RNA-seq data, DaPars [11] , to have limited reproducibility, possibly because biases in read coverage along RNAs are difficult to model. To overcome these limitations, we developed PAQR, which makes use of a large catalog of PAS to segment the 3' UTRs and infer the relative use of PAS from RNA-seq data. We show that PAQR enables a more reproducible as well as accurate inference of motif activities in PAS choice compared to DaPars. PAQR strongly broadens the domain of applicability of KAPAC to include RNA sequencing data sets that have been obtained in a wide range of systems, as we have illustrated in our study of TCGA data. As single-cell transcriptome analyses currently employ protocols designed to capture RNA 3' ends, it will be especially interesting to apply our methods to single-cell sequencing data.
Conclusions
In this study, we developed PAQR, a robust computational method for inferring relative poly(A) site use in terminal exons from RNA sequencing data and KAPAC, an approach to infer sequence motifs that are associated with the processing of poly(A) sites in specific samples. We demonstrate that these methods help uncover regulators of polyadenylation in cancers and also shed light on their mechanism of action. Our study further underscores the importance of assessing the quality of samples used for high-throughput analyses, as this can have substantial impact on the estimates of gene expression. Purification Kit, #61011, Thermo Scientific). Polyadenylated RNA was subsequently processed and libraries were prepared for sequencing on the Illumina HiSeq 2500 platform as described earlier [19] . Sequencing files were processed according to Martin et al. [41] but without using the random 4-mer at the start of the sequence to remove duplicates. A-seq2 3' end processing data from control and si-HNRNPC-treated cells was obtained from a prior study [19] .
Methods
Datasets
3' end sequencing data pertaining to PCBP1
3' end sequencing data from control and si-PCPB1-treated cells were downloaded from SRA (accession: SRP022151) and converted to fastq format. Reverse complemented and duplicate-collapsed reads were then mapped to the human genome with segemehl version 0.1.7 [42] . We did not use STAR for these data set because these libraries, generated by DRS (direct RNA sequencing) had a high fraction of short reads that STAR did not map.
From uniquely mapped reads for which at least the last 4 nucleotides at the 3' end perfectly matched to the reference, the first position downstream of the 3' end of the alignment was considered as cleavage site and used for quantification of PAS use.
RNA-seq data from The Cancer Genome Atlas
BAM files for matching normal and tumor RNA-seq samples listed in Supplementary Table 3 were obtained from the Genomic Data Commons (GDC) Data Portal [43] Other RNA-seq data sets Publicly available raw sequencing data was obtained from NCBI Gene Expression Omnibus (GEO) [44] for the studies of CFIm 25 knock-down in HeLa cells [11] (accession number GSE42420), of HNRNPC knock-down in HEK293 cells [28] (GSE56010) and for HEK293 cells expressing mutated versions of POLR2A that have overall different rates of RNAPII transcription elongation [36] 
(GSE63375).
PTBP1 CLIP data PTBP1-eCLIP data generated by the ENCODE consortium [30] 
Processing of the sequencing data
Raw reads obtained from RNA-seq experiments were mapped according to the RNA-seq pipeline for long RNAs provided by the ENCODE Data Coordinating Center (https://github.com/ENCODE-DCC/long-rna-seq-pipeline/blob/master/dnanexus/align-star-pe /resources/usr/bin/lrna_align_star_pe.sh) using the GENCODE version 24 human gene annotation. Raw reads from eCLIP experiments carried out by the ENCODE consortium for the PTBP1 were first trimmed with cutadapt version 1.9.1 [46] , both at the 5' and at the 3' ends to remove adapters. A second round of trimming guaranteed that no double ligation events were further processed. The reads were then mapped to the genome with STAR, version 2.5.2a [47] . Detection and collapsing of PCR duplicates was done with a custom python script similar to that described by van Nostrand et al. [26] . BAM files corresponding to biological replicates were then merged.
PAQR Inputs
PAQR requires an alignment file in BAM-format and a file with all poly(A) sites mapped on the genome, in BED-format. The assessment of RNA integrity (see below) also requires the transcript annotation of the genome, in BED12-format.
Poly(A) sites
PAQR quantifies the relative use of poly(A) sites in individual terminal exons. We started from the entire set of poly(A) sites in the PolyAsite resource [19] , but this set can be exchanged or updated, and should be provided as a BED-file to the tool. We converted the coordinates of the poly(A) sites to the latest human genome assembly version, GRCh38, with liftOver [48] . Terminal exons with more than one poly(A) site (terminal exons with tandem poly(A) sites, TETPS) and not overlapping with other annotated transcripts on the same strand were identified based on version 24 of the GENCODE [49] annotation of the genome. When analyzing RNA-seq data that was generated with an unstranded protocol, PAQR does not quantify poly(A) site usage in terminal exons that overlap with annotated transcripts on the opposite strand.
Quantification of PAS usage
The main steps of the PAQR analysis are as follows: first, the quality of the input RNA sequencing data is assessed, to exclude samples with evidence of excessive RNA degradation. Samples that satisfy a minimum quality threshold are then processed to quantify the read coverage per base across all TETPS and poly(A) sites with sufficient evidence of being processed are identified. These are called 'used' poly(A) sites (or uPAS).
Finally, the relative use of the uPAS is calculated.
Assessment of sample integrity
The integrity of RNA samples is usually assessed based on a fragment analyzer profile [50] .
Alternatively, a post hoc method, applicable to all RNA sequencing data sets, quantifies the uniformity of read coverage along transcript bodies in terms of a 'transcript integrity number' (TIN) [51] . We implemented this approach in PAQR, calculating TIN values for all transcripts containing TETPS. For the analysis of TCGA samples and of RNA-seq samples from cells with different RNAPII transcription speeds, we only processed samples with a median TIN value of at least 70, as recommended in the initial publication [51] .
RNA-seq read coverage profiles
For each sample, nucleotide-wise read coverage profiles along all TETPS were calculated based on read-to-genome alignments (obtained as described above). In processing paired-end sequencing data, PAQR ensured unique counting of reads where the two mates overlap. When the data was generated with an unstranded protocol, all reads that mapped to the locus of a specific TETPS were assumed to originate from that exon. The locus of each TETPS was extended by 200 nt at the 3' end, to ensure inclusion of the most distal poly(A) sites (see below). To accurately quantify the usage of the most proximal PAS, when poly(A) sites were located within 250 nt from the start of the terminal exon, the coverage profile was first extended upstream of the PAS based on the reads that mapped to the upstream exon(s). Specifically, from the spliced reads, PAQR identified the upstream exon with most spliced reads into the TETPS and computed its coverage. When the spliced reads that covered the 5' end of the TETPS provided evidence for multiple splice events, the most supported exons located even further upstream were also included (Supplementary Figure   4) .
Identification of the most distal poly(A) sites
From the read coverage profiles, PAQR attempted to identify the poly(A) sites that show evidence of processing in individual samples as follows. First, to circumvent the issue of incomplete or incorrect annotations of PAS in transcript databases, PAQR identified the most distal PAS in each terminal exon that had evidence of being used in the samples of interest. Thus, alignment files were concatenated to compute a joint read coverage profile from all samples of the study. Then, the distal PAS was identified as the 3'-most PAS in the TETPS for which: 1. The mean coverage in the 200 nt region downstream of the PAS was lower than the mean coverage in a region twice the read length (to improve the estimation of coverage, as it tends to decrease towards the poly(A) site) upstream of the poly(A) site, and 2. The mean coverage in the 200 nt region downstream of the PAS was at most 10 % of the mean coverage from the region at the exon start (the region within one read length from the exon start) (Supplementary Figure 5) . For samples from TCGA, where read length varied, we have used the maximum read length in the data for each cancer type. After the distal PAS was identified, PAQR considered for the relative quantification of PAS usage only those TETPS with at least one additional PAS internal to the TETPS and with a mean raw read coverage computed over the region between the exon start and distal PAS of more than five.
Identification of used poly(A) sites
PAQR infers the uPAS recursively, at each step identifying the PAS that allows the best segmentation of a particular genomic region into upstream and downstream regions of distinct coverage across all replicates of a given condition (Supplementary Figure 6) . Initially, the genomic region is the entire TETPS, and at subsequent steps genomic regions are defined by previous segmentation steps. Given a genomic region and annotated PAS within it, every PAS is evaluated as follows. The mean squared error (MSE) in read coverage relative to the mean is calculated separately for the segments upstream (MSE u ) and the downstream (MSE d ) of each PAS. A minimum length of 100 nt is required for each segment, otherwise the candidate PAS is not considered further. The sum of MSE in the upstream and downstream segments is compared with the MSE computed for the entire region (MSE t ). If (MSE u +MSE d )/MSE t ≤ 0.5 (see also below), the PAS is considered 'candidate used' in the corresponding sample. When the data set contains at least 2 replicates for a given condition, PAQR further enforces the consistency of uPAS selection in replicate samples by requiring that the PAS is considered used in at least 2 of the replicates and furthermore, for all PAS with evidence of being used in a current genomic region, the one with the smallest median MSE ratio computed over samples that support the usage of the site is chosen in a given step of the segmentation. The segmentation continues until no more PAS has sufficient evidence of being used. If the data consists of a single sample, the segmentation is done based on the smallest MSE at each step.
To further minimize incorrect segmentations due to PAS that are used in the samples of interest but not part of the input set, an additional check is carried out for each TETPS in each sample, to ensure that applying the segmentation procedure considering all positions in the TETPS rather than the annotated PAS recovers positions that fall within at most 200 nt upstream of the uPAS identified in previous steps for each individual sample. If this is not the case, the data for the TETPS from the corresponding sample is excluded from further analysis.
Treatment of closely spaced poly(A) sites
Occasionally, distinct PAS occur very close to each other. While 3' end sequencing may allow their independent quantification, the RNA-seq data does not have the resolution to distinguish between closely spaced PAS. Therefore, in the steps described above, closely 
PAQR modules
PAQR is composed of 3 modules: (1) A script to infer transcript integrity values based on the method described in a previous study [51] . The script builds on the published software which is distributed as part of the Python RSeQC package version 2.6.4 [52] . ( terminal exons we will capture only the changes that are due to alternative polyadenylation and not those that are due to overall changes in transcription rate or to alternative splicing.
We are considering k-mers of a length from 3 to 6 nucleotides in order to match the expected length of RBP binding sites [27] . 
. By fitting the relative use of poly(A) sites to the observed number of motifs around them, we can obtain the activities for each k-mer k in each sample s and A k,s calculate mean activity difference z-scores across treatment versus control pairs of samples (see Figure 1 and Supplementary methods).
Parameters used for KAPAC analysis of 3' end sequencing data
We considered terminal exons with multiple poly(A) sites within protein coding transcripts (hg38, GENCODE version 24) whose expression, inferred as previously described [19] , was at least 1 RPM in at least one of the investigated samples. To ensure that the position-dependent motif activities could be correctly assigned, exons containing expressed PAS that were closer than 400 nt from other PAS were excluded from the analysis, as we applied KAPAC to regions +/-200 nt around poly(A) sites. We randomized the associations of changes in poly(A) site use with k-mer counts 100 times in order to calculate p-values for mean activity difference z-scores (see Supplementary methods).
Parameters used for KAPAC analysis of RNA-seq data All KAPAC analyses for RNA-seq data sets considered terminal exons with at least 2 PAS of any transcripts from the GENCODE version 24 annotation of the human genome. Filtering of the closely-spaced PAS, activity inference and randomization tests were done similar to the processing of 3' end sequencing libraries. No TPM cutoff was applied as the used PAS are already determined by PAQR. percentually. Thus, when the most distal site is exclusively used the average terminal exon length is 100, while when a very proximal site is used exclusively, the average terminal exon length will be close to 0 (Supplementary Figure 7) .
Average terminal exon length
Average length difference
The difference in average length of a terminal exon between two samples is obtained by subtracting the average length inferred from one sample from the average length inferred from the second sample. 3' UTR shortening is reflected in negative average length differences, while 3' UTR lengthening will lead to positive differences.
Definition of the best MSE ratio threshold
Two studies of HNRNPC yielded 3' end sequencing [19] and RNA sequencing [28] data of control and si-HNRNPC-treated cells. We used these data to define a PAQR parameter (the threshold MSE ratio) such as to maximize the reproducibility of the results from the two studies. MSE ratio values ranging from 0.2 to 1.0 were tested, Supplementary Figure 8 .
Relative use of PAS we calculated based on the A-seq2 data sets as described before [19] .
The RNA-seq data was processed to infer PAS use with different MSE cutoffs, and the calculate average terminal exon lengths for individual exons in individual samples and also differences in average exon lengths between samples. For the comparison of the RNA-seq based PAS quantifications with those from A-seq2, we considered both the overall number of terminal exons quantified in replicate data sets as well as the correlation of average length differences. As shown in Supplementary Figure 8 stringent (low) cutoff in MSE leads to few exons being quantified with high reproducibility, but the number of quantified exons has a peak relative to the MSE. At a threshold of 0.5 on MSE we are able to quantify the largest number of exons with relatively good reproducibility, and we therefore applied this value for all our subsequent applications of PAQR.
Selection of normal -tumor sample pairs for analysis of 3' UTR shortening
For the analysis of motifs associated with 3' UTR length changes in cancers, we computed the distribution of differences in 3' UTR length between matched tumor-normal samples. We clustered the vectors of 3' UTR length changes for each cancer type separately. We then identified subclusters in which all the sample pairs showed a negative median change in 3'
UTR length. These samples were further analyzed with KAPAC.
Selection of normal -tumor pairs from GBM data
From the six processed normal samples five with similar average exon length distributions were selected (all of the being among the samples with the highest median average length) and compared to the five primary tumor samples with the lowest median average exon length.
eCLIP data analysis
We predicted targets of the CU-repeat motif as described in the Supplementary methods and obtained a total of 204 targets. We either used the entire set or divided the set into the top half and bottom half of targets. For each poly(A) site from a given set, the read coverage profiles of the 400 nt region centered on the poly(A) site were constructed from both the 
Motif profiles
Motif profiles were generated by extracting the genomic sequences (from the GRCh38 version of the human genome assembly) around poly(A) sites from a given set, scanning these sequences and tabulating the start positions where the motif occurred. The range of motif occurrence variation at a given position was calculated as the standard deviation of the mean, assuming a binomial distribution with the probability of success given by the empirical frequency (smoothened over 7 nucleotides centered on the position of interest) and the number of trials given by the number of poly(A) sites in the set.
Selection of CFIm-sensitive and insensitive terminal exons
For terminal exons with exactly two quantified poly(A) sites that were expressed with at least 3 RPM in all samples (1'776 terminal exons) we calculated the proximal distal ratio was 
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